| UBE2G1 governs the destruction of cereblon neomorphic substrates G Lu, S Weng, M Matyskiela, X Zheng, W Fang, S Wood, C Surka, ... Elife 7, e40958, 2018 | 62 | 2018 |
| Plakophilin-2 promotes tumor development by enhancing ligand-dependent and-independent epidermal growth factor receptor dimerization and activation K Arimoto, C Burkart, M Yan, D Ran, S Weng, DE Zhang Molecular and cellular biology 34 (20), 3843-3854, 2014 | 48 | 2014 |
| Hmga2 is a direct target gene of RUNX1 and regulates expansion of myeloid progenitors in mice K Lam, A Muselman, R Du, Y Harada, AG Scholl, M Yan, S Matsuura, ... Blood, The Journal of the American Society of Hematology 124 (14), 2203-2212, 2014 | 45 | 2014 |
| Multiple phosphorylation of Rad9 by CDK is required for DNA damage checkpoint activation G Wang, X Tong, S Weng, H Zhou Cell cycle 11 (20), 3792-3800, 2012 | 31 | 2012 |
| Negative effects of GM-CSF signaling in a murine model of t (8; 21)–induced leukemia S Matsuura, M Yan, MC Lo, EY Ahn, S Weng, D Dangoor, M Matin, ... Blood, The Journal of the American Society of Hematology 119 (13), 3155-3163, 2012 | 26 | 2012 |
| Sex chromosome loss and the pseudoautosomal region genes in hematological malignancies S Weng, SA Stoner, DE Zhang Oncotarget 7 (44), 72356, 2016 | 21 | 2016 |
| Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen Z Mo, S Wood, S Namiranian, R Mizukoshi, S Weng, IS Jang, C Fontanillo, ... Blood advances 5 (7), 2027-2039, 2021 | 20 | 2021 |
| The RUNX1-ETO target gene RASSF2 suppresses t (8; 21) AML development and regulates Rac GTPase signaling SA Stoner, KTH Liu, ET Andrews, M Liu, KI Arimoto, M Yan, AG Davis, ... Blood cancer journal 10 (2), 16, 2020 | 15 | 2020 |
| Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity S Weng, S Matsuura, CT Mowery, SA Stoner, K Lam, D Ran, AG Davis, ... Leukemia 31 (1), 159-169, 2017 | 15 | 2017 |
| Quantitative phosphoproteomics: New technologies and applications in the DNA damage response H Zhou, C Albuquerque, J Liang, RT Suhandynata, S Weng Cell Cycle 9 (17), 3479-3484, 2010 | 14 | 2010 |
| RUNX1–ETO induces a type I interferon response which negatively effects t (8; 21)-induced increased self-renewal and leukemia development RC DeKelver, B Lewin, S Weng, M Yan, J Biggs, DE Zhang Leukemia & lymphoma 55 (4), 884-891, 2014 | 12 | 2014 |
| The GM-CSF Receptor Alpha Chain (CSF2RA) Functions As a Novel Ligand-Independent Tumor Suppressor in t (8; 21) AML S Weng, DE Zhang Blood 126 (23), 3589, 2015 | 4 | 2015 |
| Plakophilin-2 induced EGFR phosphorylation: a focus on the intracellular activators of EGFR K Arimoto, S Weng, DE Zhang Receptors & clinical investigation 2 (1), e485, 2014 | 4 | 2014 |
| Transcriptional Repression of RASSF2 Impairs Hippo Kinase-Dependent p53 Activation and Tumor Suppression in t (8; 21) AML SA Stoner, ET Andrews, KI Arimoto, M Yan, S Weng, R Dekelver, MC Lo, ... Blood 130, 2492, 2017 | | 2017 |
| RUNX1-ETO-Dependent Transcriptional Repression of RASSF2 Contributes to t (8; 21) Leukemia through Evasion of MST1-Driven Apoptosis Signaling SA Stoner, ET Andrews, R Dekelver, S Weng, MC Lo, KL Guan, DE Zhang Blood 128 (22), 1547, 2016 | | 2016 |
| Usp18 Is Required for Normal Stem Cell Maintenance K Arimoto, Y Zhang, M Yan, S Miyauchi, S Weng, SA Stoner, T Shima, ... Blood 128 (22), 3863, 2016 | | 2016 |
| Characterization of granulocyte-macrophage colony-stimulating factor signaling in RUNX1-ETO leukemogenesis S Weng University of California, San Diego, 2016 | | 2016 |
| Blood First Edition Paper, prepublished online August 22, 2014; DOI 10.1182/blood-2014-02-554543 K Lam, A Muselman, R Du, Y Harada, AG Scholl, M Yan, S Matsuura, ... | | 2014 |
| Plakophilin-2 promotes tumor development by enhancing ligand-dependent and -independent EGF receptor dimerization and activation DEZ Kei-ichiro Arimoto, Christoph Burkart, Ming Yan, Dan Ran, Stephanie Weng Molecular and Cellular Biology, 2014 | | 2014 |
| RUNX1-ETO Expressing Hematopoietic Stem/Progenitor Cells (HSPCs) Display a Hypersensitivity To GM-CSF That Reduces Leukemogenic Potential S Weng, S Matsuura, MC Lo, K Lam, D Ran, DE Zhang Blood 122 (21), 1258, 2013 | | 2013 |
